Advances in neovascular macular degeneration, presented at ASRS 2025, include efficacy of aflibercept 8 mg as well as ...

New peptide drugs could take aim at a broader range of proteins that cause certain cancers, viral infections, and brain ...

The brain’s map of the body remains largely unaffected by amputation, potentially informing phantom limb pain management and ...

A UK study shows that ADHD in young women increased during the COVID-19 pandemic, peaking in the age group 20-24 years; ...

A deep-learning analysis of three-dimensional optical coherence tomography scans shows promising accuracy in distinguishing ...

About 23% of MRI scans of the hand or wrist may reveal an incidental finding, and only about 3% overall may need further ...

New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...

Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...

The American College of Obstetricians and Gynecologists (ACOG) has issued new guidelines on deferred umbilical cord clamping ...

Recently, second-generation anti-VEGF agents, including brolucizumab, faricimab, and 8 mg aflibercept, have become available ...

Many doctors adopt damaging lifestyle ‘survival skills’ during residency and keep them for years. Here’s how to spot — and ...

In phase 3 APOLLO trial, ATRA-ATO combination therapy showed superior outcomes for high-risk acute promyelocytic leukemia.